ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime Sleepiness

ClinicalTrials.gov ID: NCT01485770

Public ClinicalTrials.gov record NCT01485770. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 7:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Four-week, Double-blind, Placebo-controlled, Randomized, Cross-over Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness

Study identification

NCT ID
NCT01485770
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Jazz Pharmaceuticals
Industry
Enrollment
33 participants

Conditions and interventions

Conditions

Interventions

  • ADX-N05 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2011
Primary completion
Apr 30, 2012
Completion
Apr 30, 2012
Last update posted
Jul 5, 2021

2011 – 2012

United States locations

U.S. sites
10
U.S. states
7
U.S. cities
9
Facility City State ZIP Site status
Pulmonary Associates Phoenix Arizona 85006
Clinical Research Group of St. Petersburg St. Petersburg Florida 33707
Neurotrials Research, Inc. Atlanta Georgia 30342
Sleep Disorders Center of Georgia Atlanta Georgia 30342
SleepMed of Central Georgia Macon Georgia 31201
The Center for Sleep and Wake Disorders Chevy Chase Maryland 20815
Mercy St. Anne Sleep Disorders Center Toledo Ohio 43623
SleepMed of South Carolina Columbia South Carolina 29201
Future Search Trials of Neurology Austin Texas 78731
Sleep Medicine Associates of Texas Dallas Texas 75231

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01485770, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 5, 2021 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01485770 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →